Rx Fundamental Growth Fund Institutional Class (FMFGX)

12.63
Net Asset Value
-0.79%
1 Day
+7.49%
Year-to-Date
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
1.63%
Expense Ratio
--
Morningstar Risk Rating™
Investment Objective The investment seeks capital appreciation. The fund's investment sub-advisor, Navellier & Associates, Inc. (the "Sub-Advisor"), seeks to achieve the fund's investment objective of capital appreciation by principally investing in stocks that the Sub-Advisor believes to have above-average growth potential relative to their peers. It invests principally in common stocks and is not limited in its investments by market capitalization.

Performance

1 month+0.72% 3 years--
3 months+7.49% 5 years--
1 year+13.89% Since inception+18.02%
Data through --

Peer Comparisonvs. Mid-cap growth

 FMFGXCategory
Performance 5-yr return--+14.76%
Expense ratio1.63%1.33%
Risk 5 year sharpe ratio--1.01
Net assets$49.2M$1.3B
Average market cap$13.8B$9.8B
Average P/E21.224.3
Portfolio turnover----

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyFolioMetrix
Fund manager & tenureLouis Navellier / 1 Years
Minimal initial investment$250.00
Minimum IRA investment--

Holdings

U.S. stock86.34%
International stock13.21%
Cash0.45%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
SWKS Skyworks Solutions Inc2.96%
RAI Reynolds American2.91%
MO Altria Group2.84%
AAPL Apple2.80%
GILD Gilead Sciences2.76%
HCP HCP Inc2.61%
VIPS Vipshop Holdings Ltd2.59%
ACT Actavis2.45%
PANW Palo Alto Networks Inc2.40%
AVGO Avago Technologies Ltd2.34%

To view my watchlist

Not a member yet?

Sign up now for a free account